Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
COVID-19
•
General Rheumatology
•
Inflammatory arthritis
What is your approach to management of inflammatory arthritis in the setting of multisystem inflammatory syndrome in adults (MIS-A) after COVID?
Related Questions
Do you regularly recommend an immunological workup for patients with suspected immunodeficiency or defer to immunology?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How do you weigh the risks and benefits of GLP-1 RAs in patients over age 65 specifically in regards to loss of muscle mass and osteoporosis?
How do you approach the treatment of patients with Ehlers-Danlos hypermobile type with chronic muscle spasms with minimal exertion?
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
Can lupus anticoagulant be positive despite a normal aPTT?
How do you counsel patients with depression about the role exercise may play in alleviating depressive symptoms?
Can inflammatory arthritis develop in patients with a history of chronic hepatitis B?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
Is there any benefit to checking serum viscosity in patients with autoimmune disease and headaches/migraines to see if aspirin or clopidogrel may be beneficial?
